CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult drug associated with AE in pediatric used to treat disease Lipoxygenase Inhibitors [MoA] Glucocorticoid Receptor Agonists [MoA] Adrenal Insufficiency [Disease/Finding] Chickenpox [Disease/Finding] Collagen Diseases [Disease/Finding] Conjunctivitis [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Edema [Disease/Finding] Gastrointestinal Diseases [Disease/Finding] Hematologic Diseases [Disease/Finding] Herpes Simplex [Disease/Finding] Hypersensitivity [Disease/Finding] Inflammation [Disease/Finding] Keratitis [Disease/Finding] Mycoses [Disease/Finding] Neoplasms [Disease/Finding] Respiratory Tract Diseases [Disease/Finding] Rheumatic Diseases [Disease/Finding] Skin Diseases [Disease/Finding] Keratitis, Herpetic [Disease/Finding] Prednisolone [Chemical/Ingredient] Carbohydrate Metabolism Alteration [PE] Decreased Glucocorticoid Secretion [PE] Decreased Leukotriene Activity [PE] Decreased Lysosomal Function [PE] Decreased Prostaglandin Activity [PE] Decreased Protein Synthesis [PE] Decreased Thromboxane Activity [PE] Lipid Metabolism Alteration [PE] Decreased Polymorphonuclear Leukocyte Migration [PE] Decreased Fibroblast Migration [PE] Decreased Capillary Permeability [PE] P [Preparations] PREDNISOLONE http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/40323lbl.pdf Active 4017988 C0032950 8638 C19114 <VANDF_Record>50.6^318^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>318</VA_IEN> PREDNISOLONE N0000146334 Ingredient prednisolone 9PHQ9Y1OLM <VANDF_Record>50.416^585^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>585</VA_IEN> collagen disease convulsion AE muscular weakness AE vertigo AE cataract AE duodenal ulcer AE impaired healing AE sodium retention AE menstrual disorder AE fluid retention AE growth suppression AE